Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor in COPD and Chronic Bronchitis (TOPIC)
NCT04066751Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ivacaftor in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by University of Alabama at Birmingham. Planned start Dec 2021; status: withdrawn.
02
Drugs
ivacaftor
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT04066751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066751.